Table 6.
After treatment |
Before treatment, n (%)
|
Kappa | P value | |||
Mild
|
Moderate
|
Severe
|
||||
All patients | Asymptomatic | 3 (50.0) | 2 (6.5) | 4 (8.3) | 0.021 | 0.648 |
Mild | 3 (50.0) | 22 (71.0) | 17 (35.4) | |||
Moderate | 0 (0) | 6 (19.4) | 17 (35.4) | |||
Severe | 0 (0) | 1 (3.2) | 10 (20.8) | |||
Group 1 | Asymptomatic | 2 (66.7) | 1 (6.7) | 2 (8.0) | 0.013 | 0.840 |
Mild | 1 (33.3) | 11 (73.3) | 9 (36.0) | |||
Moderate | 0 (0) | 3 (20.0) | 9 (36.0) | |||
Severe | 0 (0) | 0 (0) | 5 (20.0) | |||
Group 2 | Asymptomatic | 1 (33.3) | 1 (6.2) | 2 (8.7) | 0.031 | 0.649 |
Mild | 2 (66.7) | 11 (68.8) | 8 (34.8) | |||
Moderate | 0 (0) | 3 (18.8) | 8 (34.8) | |||
Severe | 0 (0) | 1 (6.2) | 5 (21.7) |
Group 1: Low fermentable oligo, di- and monosaccharides and polyols (FODMAP) diet + probiotic, Group 2: low fermentable oligo, di- and monosaccharides and polyols diet + placebo.